Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) Assets (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted Assets of $361.69 million for Q2 2026, down 8.1% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals' Assets came in at $312.93 million, up 833.2% from FY2024.

  • In prior years, Lb Pharmaceuticals' Assets was $33.53 million in FY2024.
  • Quarterly Assets has run from a low of $33.53 million in Q4 2024 to a high of $393.48 million in Q1 2026 over five years.
  • According to Business Quant data, Assets for the three prior quarters was $393.48 million (Q1 2026), $312.93 million (Q4 2025) and $320.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn - 453.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 453.37 Mn
Jun 30, 2026 361.69 Mn
Mar 31, 2026 393.48 Mn
Dec 31, 2025 312.93 Mn
Sep 30, 2025 320.75 Mn
Dec 31, 2024 33.53 Mn
API Access

Lb Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=LBRX&period=max&api_key=YOUR_API_KEY